TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from EC Healthcare ( (HK:2138) ) is now available.
EC Healthcare reported its interim financial results for the six months ending September 30, 2025, showing a decline in total revenue by 6.4% compared to the previous year. The company experienced a significant drop in net profit by 89.5%, primarily due to decreased revenue in its medical segment and increased costs. Despite these challenges, the aesthetic medical and beauty segment saw a growth of 7.3%. The financial results indicate a challenging period for EC Healthcare, impacting its profitability and market positioning.
The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.
More about EC Healthcare
EC Healthcare operates in the healthcare industry, offering a range of services including medical, aesthetic medical and beauty, wellness, and veterinary services. The company is focused on providing comprehensive healthcare solutions and maintains a significant presence in these markets.
Average Trading Volume: 557,411
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$699.3M
See more insights into 2138 stock on TipRanks’ Stock Analysis page.